Virginia Tech®home

About Us

Learn more about the Fralin Biomedical Research Institute at VTC

Loading player for

As one of the nation’s fastest-growing research enterprises, the Fralin Biomedical Research Institute at VTC is a destination for world-class researchers. The institute’s scientists focus on diseases that are the leading causes of death and suffering in the United States, including brain disease, heart disease, and cancer. In just 10 years, the research institute has experienced unprecedented growth: doubling its enterprise and lab facilities in Roanoke, while also securing laboratory space on the Children’s National Research & Innovation Campus in Washington, D.C., to expand Virginia Tech’s Cancer Research Alliance and study pediatric brain and spinal cord cancers. We are committed to making our workplace inclusive for everyone. Read our Fralin Biomedical Research Institute Principles of Human Dignity and Non-Discrimination

Our mission

The Fralin Biomedical Research Institute makes transformative scientific advances to improve the human experience.

We seek to:
  • Understand the fundamental processes of human health and disease.
  • Apply those advances to the improvement of health through improved prevention, diagnostics and therapeutics.
  • Train the next generation of biomedical science leaders.
  • Enhance discovery-based medical education.
  • Sustain and strengthen the Virginia Tech Carilion academic medicine partnership, developing one of the nation’s premier biomedical and health sciences research ecosystems.


  • In 2019, the research institute had a $114 million research grant portfolio.
  • Our faculty members also train students enrolled in Virginia Tech undergraduate and graduate programs, including the Translational Biology, Medicine, and Health (TBMH) program. Roughly one in ten TBMH doctoral students will land a NIH award before they graduate. TBMH graduates have pursued positions at Harvard Medical School, Stanford University, and the NIH.
  • The institute is the hub for the worldwide hyperscanning network for interactive human functional brain imaging, which includes three research-dedicated 3.0 Tesla MRIs, an MR-guided human-focused ultrasound system, a high-field cryo-electron microscopy facility, multiple behavioral testing suites, a transcranial magnetic stimulation facility, laser scanning confocal and multi-photon imaging systems, molecular biology and electrophysiology suites, a state-of-the-art fluorescence activated cell-sorting facility, super resolution microscopy, and a new optically pumped magnetometry suite.